Literature DB >> 29196207

Inflammation and fibrosis.

Matthias Mack1.   

Abstract

Tissue damage and inflammation are important triggers for regeneration and fibrosis. Tissue damage not only induces inflammation in general, it also determines the type and polarization of inflammation by recruiting and activating a variety of different cells types of the innate and adaptive immune system. This review focuses on the pathways leading from tissue damage to inflammation, from inflammation to fibrosis and from fibrosis to function. It covers the pro- and antifibrotic properties of immunological mediators released from T cells, monocytes/macrophages, innate lymphoid cells, basophils and eosinophils and takes into account that extracellular matrix proteins are not only produced by mesenchymal fibroblasts but also by other cell types, especially infiltrating hematopoietic cells. The special requirements for activation and recruitment of these so called fibrocytes are described in detail.
Copyright © 2017 International Society of Matrix Biology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fibrocytes; Fibrosis; Inflammation; Tissue damage

Mesh:

Substances:

Year:  2017        PMID: 29196207     DOI: 10.1016/j.matbio.2017.11.010

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  97 in total

Review 1.  Hyaluronan biology: A complex balancing act of structure, function, location and context.

Authors:  Stavros Garantziotis; Rashmin C Savani
Journal:  Matrix Biol       Date:  2019-02-23       Impact factor: 11.583

2.  Molecular characterization of a precision-cut rat liver slice model for the evaluation of antifibrotic compounds.

Authors:  Xinqiang Huang; Hong Cai; Ron Ammar; Yan Zhang; Yihe Wang; Kandasamy Ravi; John Thompson; Gabor Jarai
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-11-08       Impact factor: 4.052

3.  Not all fiber is good for you: targeting fibroblast activation to improve cardiac function in heart failure.

Authors:  Kristofer J Haushalter; Hemal H Patel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-07-13       Impact factor: 4.733

Review 4.  Bone morphogenetic protein signaling in inflammation.

Authors:  David H Wu; Antonis K Hatzopoulos
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-07

Review 5.  Sick fat: the good and the bad of old and new circulating markers of adipose tissue inflammation.

Authors:  I Barchetta; F A Cimini; G Ciccarelli; M G Baroni; M G Cavallo
Journal:  J Endocrinol Invest       Date:  2019-05-09       Impact factor: 4.256

6.  T-cell regulation of fibroblasts and cardiac fibrosis.

Authors:  Amy D Bradshaw; Kristine Y DeLeon-Pennell
Journal:  Matrix Biol       Date:  2020-05-11       Impact factor: 11.583

7.  Engineering clinically-relevant human fibroblastic cell-derived extracellular matrices.

Authors:  Janusz Franco-Barraza; Kristopher S Raghavan; Tiffany Luong; Edna Cukierman
Journal:  Methods Cell Biol       Date:  2020-01-21       Impact factor: 1.441

8.  Molecular pathology of human knee arthrofibrosis defined by RNA sequencing.

Authors:  Banu Bayram; Afton K Limberg; Christopher G Salib; Jacob W Bettencourt; William H Trousdale; Eric A Lewallen; Nicolas Reina; Christopher R Paradise; Roman Thaler; Mark E Morrey; Joaquin Sanchez-Sotelo; Daniel J Berry; Andre J van Wijnen; Matthew P Abdel
Journal:  Genomics       Date:  2020-03-05       Impact factor: 5.736

Review 9.  CD44-dependent inflammation, fibrogenesis, and collagenolysis regulates extracellular matrix remodeling and tensile strength during cutaneous wound healing.

Authors:  Priya Govindaraju; Leslie Todd; Snehal Shetye; James Monslow; Ellen Puré
Journal:  Matrix Biol       Date:  2018-06-09       Impact factor: 11.583

Review 10.  Thyroid-associated ophthalmopathy: Emergence of teprotumumab as a promising medical therapy.

Authors:  Terry J Smith
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2020-01-31       Impact factor: 4.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.